Immunobiological properties of a mixture of antigens from experimental protective protein-containing fractions isolated by different methods from the Streptococcus oralis strain

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Previously, the main pathogenicity factors of closely related strains of Mitis group streptococci of different virulence, including Streptococcus pneumoniae and Streptococcus oralis, were determined. Differences in the protein composition of protein-containing fractions (PCF) with a molecular weight of 30–100 kDa isolated from them using Amicon®Ultra filters (Millipore, Ireland) were established. It was of interest to obtain PCF by gel filtration (PCF-C) and the determination of the possibility of its use in the development of an antipneumococcal drug.

Aim. Comparison of the immunobiological properties of PCF from the S. oralis strain isolated by different methods and a study of the protective activity of a mixture of antigens of the Mitis group of streptococci.

Materials and methods. PCF-C was prepared by exclusion chromatography on a Toyopearl HW-55 column. Surface protein-containing antigens of S. oralis were assessed by protein content using the Lowry method and electrophoretic characteristics using the Laemmli method. The protective activity was studied in experiments on active protection of BALB / c mice with two intraperitoneal injections (with an interval of 14 days) of three preparations: PCF and PCF-C (50 μg protein / mouse) and a mixture of PCF-C + recombinant atoxic pneumolysin (raPly) (25 μg protein / mouse). Immunized mice were intranasally infected with a virulent strain of S. pneumoniae serotype 3 No. 10196. The level of specific immunoglobulin G (IgG) antibodies was determined in the hyperimmune sera of mice using solid-phase enzyme-linked immunosorbent assay. Statistical processing of the results was performed using parametric and nonparametric comparison methods.

Results. A comparative analysis of the PCF-C and PCF series established their protective activity against the virulent strain of S. pneumoniae; both preparations induced the production of specific IgG antibodies, did not differ in protein yield and were non-toxic. The protective activity of the PCF-C + raPly mixture was established.

Conclusion. The feasibility of using a surface protein-containing antigen of S. oralis obtained using size-exclusion chromatography, including as part of a two-component experimental preparation in a mixture with raPly not sorbed on aluminum hydroxide, is demonstrated.

About the authors

Olga M. Afanasyeva

I. I. Mechnikov Research Institute of Vaccines and Serums

Author for correspondence.
Email: kukina1994@mail.ru
ORCID iD: 0000-0003-0875-4141
Russian Federation, 5A Maly Kazenny Lane, Moscow 105064

Irina M. Gruber

I. I. Mechnikov Research Institute of Vaccines and Serums

Email: kukina1994@mail.ru
ORCID iD: 0000-0002-1922-4640
Russian Federation, 5A Maly Kazenny Lane, Moscow 105064

Denis S. Vorobyev

I. I. Mechnikov Research Institute of Vaccines and Serums

Email: kukina1994@mail.ru
ORCID iD: 0000-0002-1926-8803
Russian Federation, 5A Maly Kazenny Lane, Moscow 105064

Lyubov N. Nesterenko

I. I. Mechnikov Research Institute of Vaccines and Serums

Email: kukina1994@mail.ru
ORCID iD: 0000-0002-3825-3906
Russian Federation, 5A Maly Kazenny Lane, Moscow 105064

Galina I. Alatortseva

I. I. Mechnikov Research Institute of Vaccines and Serums

Email: kukina1994@mail.ru
ORCID iD: 0000-0001-9887-4061
Russian Federation, 5A Maly Kazenny Lane, Moscow 105064

Natalia E. Yastrebova

I. I. Mechnikov Research Institute of Vaccines and Serums

Email: kukina1994@mail.ru
ORCID iD: 0000-0002-6911-1345
Russian Federation, 5A Maly Kazenny Lane, Moscow 105064

Olga V. Zhigunova

I. I. Mechnikov Research Institute of Vaccines and Serums

Email: kukina1994@mail.ru
ORCID iD: 0000-0002-3958-6219
Russian Federation, 5A Maly Kazenny Lane, Moscow 105064

References

  1. Chan W.Y., Entwisle C., Ercoli G. et al. Corrected and republished from: “A novel, multiple-antigen pneumococcal vaccine protects against lethal Streptococcus pneumoniae challenge”. Infect Immun 2022;90:e00846–18a. doi: 10.1128/IAI.00846-18a
  2. Morais V., Texeira E., Suarez N. Next-generation whole-cell pneumococcal vaccine. Vaccines (Basel) 2019;7(4):151. doi: 10.3390/vaccines7040151
  3. Keech C.A., Morrison R., Anderson P. et al. A phase 1 randomized, placebo-controlled, observer-blinded trial to evaluate the safety and immunogenicity of inactivated Streptococcus pneumoniae whole-cell vaccine in adults. Pediatr Infect Dis J 2020;39(4):345–51. doi: 10.1097/INF.0000000000002567
  4. Masomian M., Ahmad Z., Gew L.T., Poh C.L. Development of next generation Streptococcus pneumoniae vaccines conferring broad protection. Vaccines (Basel) 2020;8(1):132. doi: 10.3390/vaccines8010132
  5. Aceil J., Avci F.Y. Pneumococcal surface proteins as virulence factors, immunogens, and conserved vaccine targets. Front Cell Infect Microbiol 2022;12:832254. doi: 10.3389/fcimb.2022.832254
  6. Афанасьева О.М., Грубер И.М., Бржозовская Е.А., Асташкина Е.А. Факторы патогенности близкородственных стрептококков группы Mitis разной вирулентности. В кн.: Молекулярная диагностика – 2023: сборник трудов XI Международной научно-практической конференции. М.: АО «САЙЕНС МЕДИА ПРОДЖЕКТС», 2023. С. 305–6. Afanasyeva O.M., Gruber I.M., Brzhozovskaja E.A., Astashkina E.A. Pathogenicity factors of closely related streptococci of the Mitis group with different virulence. V kn.: Molekuliarnaia diagnostika – 2023: sbornik trudov XI Mezhdunarodnoi nauchno-prakticheskoi konferentsii. Moscow: AO “SAIENS MEDIA PRODZhEKTS”, 2023. S. 305–6. (In Russ.).
  7. Афанасьева О.М., Грубер И.М., Воробьев Д.С. и др. Сравнительный анализ факторов патогенности близкородственных стрептококков группы Mitis и выделенных из них поверхностных белоксодержащих антигенов. Эпидемиология и вакцинопрофилактика. 2025;24(2):24–32. doi: 10.31631/2073-3046-2025-24-2-24-32 Afanasyeva O.M., Gruber I.M., Vorobyev D.S. et al. Comparative analysis of pathogenicity factors of closely related Mitis group streptococci and surface protein-containing antigens isolated from them. Epidemiologiya y vaktsinoprofilaktika = Epidemiology and Vaccinal Prevention. 2025;24(2):24–32. (In Russ.). doi: 10.31631/2073-3046-2025-24-2-24-32
  8. Ахматова Н.К., Грубер И.М., Кукина О.М. и др. Влияние экспериментальных белоксодержащих пневмококковых препаратов на созревание дендритных клеток у мышей. Инфекция и иммунитет 2021;11(1):85–92. doi: 10.15789/2220-7619-TEO-1218 Akhmatova N.K., Gruber I.M., Kukina O.M. et al. Effects of experimental protein-containing pneumococcal preparations on maturation of murine dendritic cells. Infektsiya y immunitet = Russian Journal of Infection and Immunity 2021;11(1):85–92. (In Russ.). doi: 10.15789/2220-7619-TEO-1218
  9. Воробьев Д.С., Сидоров А.В., Калошин А.А. и др. Получение рекомбинантной формы белка пневмолизина Streptococcus pneumoniae. Бюллетень экспериментальной биологии и медицины 2022;174(12):723–7. doi: 10.47056/0365-9615-2022-174-12-723-727 Vorobyev D.S., Sidorov A.V., Kaloshin A.A. et al. Preparation a recombinant form of pneumolysin protein from Streptococcus pneumoniae. Bulleten experimentalnoy biologii y meditsiny = Bulletin of Experimental Biology and Medicine 2022;174(12):723–7. (In Russ.). doi: 10.47056/0365-9615-2022-174-12-723-727
  10. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193(1):265–75. PMID: 14907713
  11. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227(5259):680–5. doi: 10.1038/227680a0
  12. Ванеева Н.П., Ястребова Н.Е. Специфический иммунный ответ к отдельным капсульным полисахаридам Streptococcus pneumoniae у здоровых доноров крови и лиц, иммунизированных пневмококковыми вакцинами. Журнал микробиологии, эпидемиологии и иммунобиологии 2015;92(5):20–6. Vaneeva N.P., Yastrebova N.E. Specific immune response to certain capsule polysaccharides of Streptococcus pneumoniae in healthy blood donors and individuals immunized with pneumococcal vaccines. Zhurnal mikrobiologii, epidemiologii y immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology 2015;92(5):20–6. (In Russ.).
  13. Hoover J.L., Lewandowski T.F., Mininger C.L. et al. A robust pneumonia model in immunocompetent rodents to evaluate antibacterial efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii. J Vis Exp 2017;119:e55068. doi: 10.3791/55068
  14. Кукина О.М., Грубер И.М., Ахматова Н.К. и др. Исследование иммунобиологических свойств поверхностных белоксодержащих антигенов Streptococcus pneumoniaе серотипа 6B. Эпидемиология и вакцинопрофилактика 2020;19(3):21–7. doi: 10.31631/2073-3046-2020-19-3-21-27 Kukina O.M., Gruber I.M., Akhmatova N.K. et al. Study of the immunobiological properties of surface protein-containing antigens of Streptococcus pneumoniae serotype 6B. Epidemiologiya y vaktsinoprofilaktika = Epidemiology and Vaccinal Prevention 2020;19(3):21–7. (In Russ.). doi: 10.31631/2073-3046-2020-19-3-21-27
  15. Воробьев Д.С., Петухова Е.С., Волох Ю.В., Семенова И.Б. Исследование иммунобиологических свойств рекомбинантного пневмолизина Streptococcus pneumoniae. Бюллетень экспериментальной биологии и медицины 2024;177(2):220–4. doi: 10.47056/0365-9615-2024-177-2-220-224 Vorobyev D.S., Petukhova E.S., Volokh Yu.V., Semenova I.B. Study of immunobiologic properties of recombinant Streptococcus pneumoniae pneumolysin. Bulleten experimentalnoy biologii y meditsiny = Bulletin of Experimental Biology and Medicine 2024;177(2):220–4. (In Russ.) doi: 10.47056/0365-9615-2024-177-2-220-224

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2026 ABV-Press

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-53039 от  04.03.2013.